LegalJun 25, 2026, 04:37 PM
InMode Sued for Patent Infringement Over Morpheus8 Devices
AI Summary
InMode Ltd. announced that Serendia LLC filed a patent infringement lawsuit against the company and its subsidiary, Invasix Inc., on June 22, 2026. The complaint, filed in the U.S. District Court for the Central District of California, alleges infringement of four U.S. patents by InMode's microneedling dermatological treatment devices, including its Morpheus8 products. Serendia is seeking unspecified damages and an injunction. A parallel complaint was also filed with the International Trade Commission. InMode plans to vigorously defend against the allegations.
Key Highlights
- Serendia LLC filed a complaint against InMode Ltd. and Invasix Inc. on June 22, 2026.
- The lawsuit alleges infringement of four U.S. patents by InMode's microneedling dermatological treatment devices, including Morpheus8 products.
- Serendia seeks unspecified damages and an injunction against the importation and sale of the accused products.
- A parallel complaint was filed with the International Trade Commission (ITC) seeking a limited exclusion order and a cease-and-desist order.
- InMode intends to deny infringement, assert patent invalidity, and vigorously defend against the claims.
- The company is currently unable to estimate a range of loss from the lawsuit.
Price Impact
More from INMD